Despite the fact that the existing literature does not explicitly establish the misinterpretation of opiate withdrawal/abuse as fibromyalgia, it does address associated difficulties. The article “Opioid usage, misuse, and abuse in patients classified as fibromyalgia” by Fitzcharles et al. provides an example. The author of the piece expresses concern regarding the long-term implications of opioid medication. The report also mentions that there is a scarcity of knowledge about opiate treatment for fibromyalgia patients.
Drug therapy is traditionally utilised for pain problems, including fibromyalgia, according to Fitzcharles et al. Furthermore, in the previous 20 years, there has been a significant surge in opioid addiction, with tragic effects. The authors believe that the risk-benefit ratio of opioid medication for the treatment of pain-related illnesses raises serious concerns. The authors go on to say that people diagnosed with fibromyalgia who are being treated with opioids have a “poor health and psychosocial status.”
Cunningham et al. wrote about “Opioid tapering in fibromyalgia patients: Experience from an interdisciplinary pain rehabilitation programme” in another study about fibromyalgia and opioid use. While current recommendations do not suggest the use of opioids in the treatment of fibromyalgia, approximately 30% of the patient population still uses opioids for pain management, according to the authors of this study. Cunningham et al. additionally offer strategies for opioid reduction and withdrawal symptom surveillance in patients receiving opioid treatment.
Cunningham et al. also found that, despite the fact that patients on high dosages of opioids had to go through a longer taper, there was no difference in withdrawal symptoms. Furthermore, the duration of opioid use had no effect on withdrawal symptoms or taper time. Despite the tapering of opioids, “pain-related metrics improved,” according to the study’s encouraging findings.
Another piece on fibromyalgia and opioid use/abuse comes from Ballantyne, who says that fibromyalgia is a poorly known disorder that may be devastating, with muscle pain being the most common complaint. Patients with the syndrome were given tiny doses of naltrexone, a medicine widely used following detoxification to reduce cravings for opiate narcotics, according to Ballantyne.
To Wrap It Up
These articles provide an overview of what has been published in the literature and studies around opiate use and fibromyalgia. It also demonstrates that further research is required to adequately address the question of “Can opioid withdrawal/abuse be misdiagnosed as fibromyalgia?” There are numerous treatment alternatives available to alleviate the pain associated with fibromyalgia while lowering the hazards of long-term opiate medication.